TRex Bio (TRXB) files S-1 for Nasdaq IPO in the 2026 listing surge
TRex Bio, Inc. filed an S-1 with the SEC on September 18, 2026, to list on Nasdaq. Five underwriters are involved, but no price range, share count, or deal size has been set. The next amendment will provide key details for investors.




